Immunotherapy with monomethoxypolyethylene glycol modified allergens.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Critical reviews in therapeutic drug carrier systems

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 2186872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation of protein conjugates with alkoxypolyethylene glycols.

  2009cited by this paper
• Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract

  1989cited by this paper
• Treatment of hay fever by Allerglobuline: a randomized double‐blind study

  1988cited by this paper
• Detection of human auto-anti-idiotypic antibodies (Ab2). II. Generation of Ab2 in atopic patients undergoing allergen immunotherapy.

  1988cited by this paper
• Diagnosis and immunotherapy of mould allergy

  1988cited by this paper
• Histamine-releasing factors and IgE heterogeneity.

  1988cited by this paper
• Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance.

  1988cited by this paper
• Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen

  1988cited by this paper
• The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.

  1988cited by this paper
• Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite

  1988cited by this paper
• Detection of human auto-anti-idiotypic antibodies (Ab2). I. Isolation and characterization of Ab2 in the serum of a ragweed immunotherapy-treated patient.

  1988cited by this paper
• Modification of house dust mite allergens by monomethoxypolyethylene glycol. Allergenicity measured by in vitro and in vivo methods.

  1988cited by this paper
• Peptide synthesis catalyzed by polyethylene glycol‐modified chymotrypsin in organic solvents

  1988cited by this paper
• In vitro studies of degradation of birch and timothy pollen allergen preparations by human duodenal juice

  1988cited by this paper
• Does the effect of immunotherapy last after termination of treatment?

  1988cited by this paper
• Immunotherapy for nasal allergy.

  1988cited by this paper
• High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens

  1987cited by this paper
• Fatalities from immunotherapy (IT) and skin testing (ST)

  1987cited by this paper
• Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model.

  1987cited by this paper
• Combination of passive and active immunization in honeybee venom immunotherapy.

  1987cited by this paper
• A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results.

  1987cited by this paper
• Airway hyperresponsiveness: therapeutic implications.

  1987cited by this paper
• Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent.

  1987cited by this paper
• Diagnosis and immunotherapy of mould allergy

  1987cited by this paper
• Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.

  1987cited by this paper
• Tolerogenic polyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins.

  1987cited by this paper
• High dose grass pollen tablets used for hyposensitization in hay fever patients

  1987cited by this paper
• Oral immunotherapy: a way forward?

  1987cited by this paper
• A double-blind study comparing monomethoxy polyethylene glycol-modified honeybee venom and unmodified honeybee venom for immunotherapy. I. Clinical results.

  1987cited by this paper
• Diagnosis and immunotherapy of mould allergy. IV. Relation between asthma symptoms, spore counts and diagnostic tests.

  1986cited by this paper
• Local intranasal immunotherapy with high-dose polymerized ragweed extract.

  1986cited by this paper
• Oral Immunotherapy of Children with Rhinoconjunctivitis due to Birch Pollen Allergy A Double Blind Study

  1986cited by this paper
• Detection of allergens in mould and mite preparations by a nitrocellulose electroblotting technique.

  1986cited by this paper
• Diagnosis and Immunotherapy of Mould Allergy

  1986cited by this paper
• A Double‐Blind, Multicenter Immunotherapy Trial in Children, Using a Purified and Standardized Cladosporium herbarum Preparation I. Clinical Results

  1986cited by this paper
• A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol.

  1986cited by this paper
• Anti-idiotypes to anti-Lolp I (Rye) antibodies in allergic and non-allergic individuals. Influence of immunotherapy.

  1986cited by this paper
• Chemical modification of tryptophanase from E. coli with polyethylene glycol to reduce its immunoreactivity towards anti-tryptophanase antibodies.

  1986cited by this paper
• A Preliminary Study of Immunotherapy with a Monomethoxy Polyethylene Glycol Modified Honey Bee Venom Preparation

  1986cited by this paper
• IgG and IgE Antibody Patterns after Immunotherapy with Monomethoxy Polyethyleneglycol Modified Honey Bee Venom

  1986cited by this paper
• Clinical and Immunological Effects of Oral Immunotherapy with a Standardized Birch Pollen Extract

  1986cited by this paper
• Cross‐reactivity between deciduous trees during immunotherapy. I. In vivo results

  1986cited by this paper
• Polyethylene glycol-modified ragweed extract: comparison of two treatment regimens.

  1986cited by this paper
• Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite

  1986cited by this paper
• Diagnosis and Immunotherapy of Mould Allergy

  1985cited by this paper
• Mechanism of poly(ethylene glycol) interaction with proteins.

  1985cited by this paper
• Polyethylene glycol-modified ragweed pollen extract in rhinoconjunctivitis.

  1985cited by this paper
• Surface modification of proteins activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase

  1985cited by this paper
• Characterization of allergens and patient sera by a nitrocellulose immunoprint technique.

  1985cited by this paper
• Immune responses to polyethylene glycol modified L-asparaginase in mice.

  1985cited by this paper
• Dust mite avoidance in the treatment of asthma.

  1985cited by this paper
• Suppression of late-phase skin reactions by immunotherapy with ragweed extract.

  1985cited by this paper
• Allergenicity, immunogenicity, and safety of immunotherapy with various molecular weight ranges of polymerized ragweed.

  1985cited by this paper
• Damage of the airway epithelium and bronchial reactivity in patients with asthma.

  1985cited by this paper
• The Subclass Nature and Clinical Significance of the IgG Antibody Response in Patients Undergoing Allergen‐Specific Immunotherapy

  1985cited by this paper
• Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.

  1985cited by this paper
• Modified forms of allergen immunotherapy.

  1985cited by this paper
• Polyethylene glycol-modified catalase exhibits unexpectedly high activity in benzene.

  1984cited by this paper
• Induction of tolerance in mice by uricase and monomethoxypolyethylene glycol-modified uricase.

  1984cited by this paper
• Immunotherapy with Alginate‐Conjugated and Alum‐Precipitated Grass Pollen Extracts in Patients with Allergic Rhinoconjunctivitis

  1984cited by this paper
• Chymotrypsin modified with polyethylene glycol catalyzes peptide synthesis reaction in benzene

  1984cited by this paper
• A chemical modification to make horseradish peroxidase soluble and active in benzene.

  1984cited by this paper
• Beclomethasone Dipropionate

  1984cited by this paper
• Comparative studies on tree pollen allergens. VII. Monomethoxy polyethylene glycol conjugation of the major allergen of birch pollen (Betula verrucosa).

  1984cited by this paper
• Immunologic responses to conjugates of antigen E in patients with ragweed hay fever.

  1984cited by this paper
• Ester synthesis catalyzed by polyethylene glycol-modified lipase in benzene.

  1984cited by this paper
• Dose response of IgE and IgG antibodies during ragweed immunotherapy.

  1984cited by this paper
• A rapid procedure for crossed radio immunoelectrophoresis.

  1983cited by this paper
• Coupling of Monomethoxypolyethyleneglycols to Proteins via Active Esters

  1983cited by this paper
• Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.

  1983cited by this paper
• Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.

  1983cited by this paper
• Anti‐inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters

  1983cited by this paper
• A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin.

  1983cited by this paper
• Modification of amino groups in porcine pancreatic elastase with polyethylene glycol in relation to binding ability towards anti-serum and to enzymic activity.

  1983cited by this paper
• Antibody responses to honey-bee venom and monomethoxy-polyethylene glycol-modified honey-bee venom in mice.

  1983cited by this paper
• Suppression of IgE antibody production in sensitized mice and rats by tolerogenic conjugates of synthetic hydrophilic polymers with antigen or hapten: effect on antigen-induced histamine release from peritoneal mast cells.

  1982cited by this paper
• Heterogeneity of grass pollen allergens (Dactylis glomerata) recognized by IgE antibodies in human patients sera by a new nitrocellulose immunoprint technique.

  1982cited by this paper
• SUPPRESSION OF IgE ANTIBODIES WITH CONJUGATES OF HAPTENS OR ALLERGENS AND SYNTHETIC HYDROPHILIC POLYMERS *

  1982cited by this paper
• Pharmacokinetic properties of polyethylene glycol derivatized superoxide dismutase.

  1982cited by this paper
• Immunologic properties of conjugates of ragweed antigen E with various alkoxypolyethylene glycols.

  1981cited by this paper
• Suppression of reaginic antibodies with modified allergens. IV. Induction of suppressor T cells by conjugates of polyethylene glycol (PEG) and monomethoxy PEG with ovalbumin.

  1981cited by this paper
• Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method.

  1981cited by this paper
• Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol.

  1981cited by this paper
• Immunotherapy with short ragweed fraction A:D-glutamic acid:D-lysine polymer in ragweed hay fever.

  1981cited by this paper
• Specific downregulation of IgE antibodies by tolerogenic conjugates of haptens and allergens with synthetic polymers.

  1981cited by this paper
• Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response.

  1981cited by this paper
• Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity.

  1981cited by this paper
• A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever.

  1980cited by this paper
• A study of optimum dose immunotherapy in pharmacological treatment failures.

  1980cited by this paper
• Treatment of ragweed hay fever with urea-denatured antigen E.

  1980cited by this paper
• Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol.

  1979cited by this paper
• Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D- lysine

  1979cited by this paper
• Rates of Release of Subcutaneously Injected Antigens in the Rat: Comparison of an Aqueous Preparation with Two Alum‐Precipitated Preparations

  1979cited by this paper
• Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.

  1979cited by this paper
• The immune response of patients with ragweed hay fever treated with polymerized ragweed antigens.

  1979cited by this paper
• Tolerance induction in immediate hypersensitivity

  1979cited by this paper
• Suppression of immunoglobulin E antibodies with modified allergens.

  1979cited by this paper
• Effects of passive antibody in bee venom anaphylaxis.

  1978cited by this paper
• Suppression of reaginic antibodies.

  1978cited by this paper
• Suppression of reaginic antibodies with modified allergens. II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol.

  1978cited by this paper

• Discovery of proteolytically stable monocyte locomotion inhibitory factor peptide through systematic structural optimization.

  2025cites this paper
• Polymer-based bioconjugation: engineering biomolecules and nanocarriers for advanced applications

  2025cites this paper
• Liposomes and phytosomes: Nanocarrier systems and their applications for the delivery of phytoconstituents

  2023cites this paper
• Effect of Modification Strategies on the Biological Activity of Peptides/Proteins

  2023cites this paper
• Anti-drug antibodies against the PEG moiety inhibit the procoagulant activity of therapeutic PEGylated FVIII.

  2023cites this paper
• Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy

  2022cites this paper
• Effect of Mini-PEGs Modification on the Enzymatic Digestion of D-Amino Acid-Containing Peptides under the Action of PROK*.

  2022cites this paper
• CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice

  2021cites this paper
• Liposome technologies towards colorectal cancer therapeutics.

  2021cites this paper
• SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center

  2021cites this paper
• Microfluidic production of protein loaded chimeric stealth liposomes.

  2020cites this paper
• PEG–protein conjugates

  2020cites this paper
• Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition

  2019cites this paper
• Synthesis of Mono- and Dithiols of Tetraethylene Glycol and Poly(ethylene glycol)s via Enzyme Catalysis

  2019cites this paper
• Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors.

  2019cites this paper
• Long circulating liposomes: challenges and opportunities.

  2018cites this paper
• Cationic Gelatin/Pluronic-based Nanoparticles as Novel Non-Viral Delivery Systems for Gene Therapy

  2018cites this paper
• Specific immunotherapy in allergic rhinitis.

  2017cites this paper
• Liposomal microencapsulation using the conventional methods and novel supercritical fluid processes

  2016cites this paper
• Intramolecular Hydrogen Bonds in Low-Molecular-Weight Polyethylene Glycol.

  2016cites this paper
• The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

  2016cites this paper
• PEGylated Biopharmaceuticals

  2015cites this paper
• Liposomes modified with superhydrophilic polymer linked to a nonphospholipid anchor exhibit reduced complement activation and enhanced circulation.

  2015cites this paper
• Liposomal Membrane Modification, Polymers for

  2015cites this paper
• CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES

  2014cites this paper
• Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers.

  2014cites this paper
• Discussion about several potential drawbacks of PEGylated therapeutic proteins.

  2014cites this paper
• Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer

  2014cites this paper
• Pluronic-Based Nanoparticles for Gene Therapy Applications

  2014cites this paper
• Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies.

  2014cites this paper
• Review Article BIODEGRADABLE POLYMERS: A SMART STRATEGY FOR TODAY'S CRUCIAL NEEDS

  2014cites this paper
• Preparation and characterization of poly (ethylene glycol) grafted Ca-alginate fibers by γ-irradiation for biomedical applications

  2013cites this paper
• Evolution of Reactive mPEG Polymers for the Conjugation of Peptides and Proteins

  2013cites this paper
• Folic acid conjugated magnetic drug delivery system for controlled release of doxorubicin

  2013cites this paper
• Peripheral tolerance of antigen-specific Th cells induced with polyethylene glycol-conjugate of protein antigen

  2013cites this paper
• Peptide and protein delivery using new drug delivery systems.

  2013cites this paper
• Surface Engineering of Liposomes for Stealth Behavior

  2013cites this paper
• Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer.

  2013cites this paper
• Lipases, liposomes and lipid-prodrugs

  2013cites this paper
• Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications

  2012cites this paper
• Application of targeted contrast nanoparticles for human multiple myeloma imaging

  2012cites this paper
• Fluorinated and pegylated polyaspartamide derivatives to increase solubility and efficacy of Flutamide

  2012cites this paper
• Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.

  2012cites this paper
• Studies on polymer conjugation as versatile tool for drug delivery

  2012cites this paper
• Food , drug , insect sting allergy , and anaphylaxis In situ imaging of honeybee ( Apis mellifera ) venom components from aqueous and aluminum hydroxide – adsorbed venom immunotherapy preparations

  2012cites this paper
• In situ imaging of honeybee (Apis mellifera) venom components from aqueous and aluminum hydroxide-adsorbed venom immunotherapy preparations.

  2012cites this paper
• Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.

  2011cites this paper
• Targeted liposomes to deliver DNA to cells expressing 5-HT receptors.

  2011cites this paper
• Bioconjugation of polymers: a novel platform for targeted drug delivery.

  2011cites this paper
• Synthesis of long-chain [¹⁸F]Deoxyfluoropoly(ethylene glycol) methyl ethers and their noninvasive pharmacokinetic analysis by positron emission tomography.

  2011cites this paper
• The characterisation of a recombinant cytosolic shuttle based on ricin toxin

  2011cites this paper
• Recent advances in pharmaceutical nanocarriers -current trends and future challenges.

  2011cites this paper
• Colloidal competences of new tailor-made lipids

  2010cites this paper
• Contact Urticaria with Systemic Symptoms due to Hexylene Glycol in a Topical Corticosteroid: Case Report and Review of Hypersensitivity to Glycols

  2010cites this paper
• Poly(ethylene glycol)-Grafted Polyethylenimine Modified with G250 Monoclonal Antibody for Tumor Gene Therapy

  2010cites this paper
• The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol)

  2009cites this paper
• Molecular and magnetic resonance imaging: The value of immunoliposomes.

  2009cites this paper
• Studio di sistemi supramolecolari per il delivery di proteine terapeutiche

  2008cites this paper
• PEGylation: an approach for drug delivery. A review.

  2008cites this paper
• Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients

  2007cites this paper
• Precise and comparative pegylation analysis by microfluidics and mass spectrometry.

  2006cites this paper
• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

  2006cites this paper
• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

  2006cites this paper
• Synthesis and Biodegradability of Polyaspartic Acid: A Critical Review

  2005cites this paper
• ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects.

  2003cites this paper
• Synthesis of heterobifunctional poly(ethylene glycol) with a primary amino group at one end and a carboxylate group at the other end

  2003cites this paper
• Conjugates of ovalbumin and monomethoxypolyethylene glycol abolish late allergic responses and decrease IL-4 and IL-5 mRNA expression in the rat.

  2003cites this paper
• AVOIDING UNTOWARD IMMUNE RESPONSES TO NOVEL GENE PRODUCTS

  2002cites this paper
• Synthesis and Biological Evaluation of Peg-Substituted Macromolecular Prodrugs of Mitomycin C

  2002cites this paper
• Pegnology: a review of PEG-ylated systems.

  2002cites this paper
• Modulation of the allergen-induced human IgE response in Hu-SCID mice: inhibitory effect of human recombinant IFN-gamma and allergen-derived lipopeptide.

  2001cites this paper
• Peptide and protein PEGylation: a review of problems and solutions.

  2001cites this paper
• Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics.

  2001cites this paper
• Physicochemical characterization of poly(ethylene glycol)-modified anti-GAD antibodies.

  2001cites this paper
• Glucose-Binding Property of Pegylated Concanavalin a

  2001cites this paper
• Transglutaminase-mediated dual and site-specific incorporation of poly(ethylene glycol) derivatives into a chimeric interleukin-2.

  2000cites this paper
• Aqueous two-phase systems : methods and protocols

  2000cites this paper
• Size exclusion chromatography does not require pores.

  2000cites this paper
• New derivatives of polyglutamic acid as drug carrier systems.

  2000cites this paper
• Immune tolerance induced by polyethylene glycol-conjugate of protein antigen: Clonal deletion of antigen-specific Th-cells in the thymus

  2000cites this paper
• Vaccines Against Allergies

  1999cites this paper
• Site-specific insulin conjugates with enhanced stability and extended action profile.

  1999cites this paper
• Bioconjugation in pharmaceutical chemistry.

  1999cites this paper
• Strategies for Dealing With the Immunogenicity of Therapeutic Proteins

  1999cites this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997.

  1998cites this paper
• WHO見解書 : アレルゲン免疫療法:アレルギー疾患の治療ワクチン

  1998cites this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases

  1998cites this paper
• Stabilization of substances in circulation.

  1998cites this paper
• Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 5000-modified bovine cupri-zinc superoxide dismutase.

  1997cites this paper
• Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.

  1997cites this paper
• Targeting of drugs to cell surface receptors.

  1997cites this paper
• PEG Modified Anticancer Drugs: Synthesis and Biological Activity

  1996cites this paper
• New Horizons in Allergy Immunotherapy

  1996influential citation
• Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.

  1996cites this paper
• Dual effects of allergen-mPEG conjugates. Induction of immunological suppression and inactivation of sensitized mast cells.

  1996cites this paper
• Allergy Vaccines

  1996cites this paper
• Dual Effects of Allergen-Mpeg Conjugates

  1996cites this paper
• A colorimetric assay for estimation of polyethylene glycol and polyethylene glycolated protein using ammonium ferrothiocyanate.

  1996cites this paper
• Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates.

  1995cites this paper
• Biodegradable polymers for protein and peptide drug delivery.

  1995cites this paper